PriceTargets.com logo

OTCMKTS:CHHHF - CareRx Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$4.45 As of 02/26/2021 01:00 AM ET
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New CareRx Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CHHHF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CHHHF

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 2 analysts offering 12 month price targets for CareRx in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $4.45.
Buy
The current consensus among 2 polled investment analysts is to buy stock in CareRx.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/6/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/5/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/4/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/2/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/31/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/29/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/28/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
2/4/2021DesjardinsInitiated CoverageBuy
i
6/29/2020Stifel NicolausInitiated CoverageBuy
i
(Data available from 2/28/2016 forward)
CareRx logo
CareRx Corporation provides specialty pharmacy services to seniors in Canada. The company operates a network of pharmacy fulfilment centers that provide chronic medication and other specialty clinical pharmacy services. As of August 13, 2020, it served approximately 50,000 residents in approximately 900 seniors and other communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is headquartered in Toronto, Canada.
Read More

Today's Range

Now: $4.45
$4.45
$4.45

50 Day Range

MA: N/A

52 Week Range

Now: $4.45
$0.00
$5.00

Volume

9,540 shs

Average Volume

3,063 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of CareRx?

The following Wall Street sell-side analysts have issued stock ratings on CareRx in the last twelve months: Desjardins, and Stifel Nicolaus.
View the latest analyst ratings for CHHHF.

What is the current price target for CareRx?

0 Wall Street analysts have set twelve-month price targets for CareRx in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for CareRx in the next year.
View the latest price targets for CHHHF.

What is the current consensus analyst rating for CareRx?

CareRx currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CHHHF will outperform the market and that investors should add to their positions of CareRx.
View the latest ratings for CHHHF.

What other companies compete with CareRx?

Other companies that are similar to CareRx include Asian American Medical Group, Encompass Health, FarmaForce Limited (FFC.AX), Field Trip Health, Fresenius SE & Co. KGaA, Greenbrook TMS, Healthia, JD Health International, Life Healthcare Group, Medicover AB (publ), Orpea, Ramsay Health Care, Sienna Senior Living and Tenet Healthcare.

How do I contact CareRx's investor relations team?

The company's listed phone number is 800 265 9197. The official website for CareRx is www.carerx.ca.